September 24, 2017 10:55 PM ET


Company Overview of Zenyaku Kogyo Co., Ltd.

Company Overview

Zenyaku Kogyo Co., Ltd. develops dermatological and anti-cancer drugs. Its product includes Rituxan, an anti-CD20 antibody for the treatment of B-cell Non-Hodgkin's Lymphoma. The company also develops OTC drugs. Zenyaku Kogyo Co., Ltd. was founded in 1950 and is based in Tokyo, Japan.

5-6-15 Otsuka


Tokyo,  112-8650


Founded in 1950


81 3 3946 1111


81 3 3946 1130

Key Executives for Zenyaku Kogyo Co., Ltd.

Chief Executive Officer and President
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
ACTGen, Inc. Asia
Amano Enzyme Inc. Asia
Ambicion Inc. Asia
ArBlast Co., Ltd. Asia
Argenes, Inc. Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Zenyaku Kogyo Co., Ltd., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at